Verisk Analytics (VRSK): Is a Move Toward $250 in the Cards?
Key Takeaways
- Selected price target: $250 per share, roughly 34% above Verisk's latest close near $185.79 and above the consensus analyst price target of about $237.71.
- Strongest bullish factors: A mission-critical data franchise serving the property-and-casualty insurance industry, highly recurring subscription revenue, and solid free cash flow generation.
- Biggest risks: Concerns that generative artificial intelligence could disrupt its pricing-data moat, slower organic growth, and elevated valuation relative to peers.
- Key levels: Support sits near the $155.94 52-week low and the $180 area, while resistance builds around $195–$200, the $237 consensus target, and the $250 milestone itself.
- Takeaway: A move to $250 is plausible over a longer horizon but would require reaccelerating growth and investor confidence that Verisk's data advantage withstands AI disruption.
Why the $250 Level Matters
Verisk Analytics, Inc. (VRSK) stands out as one of the more resilient data-analytics businesses, yet its shares have pulled back noticeably over the past year. After peaking near $273.83 in late 2025, the stock has eased to around $185.79, a drop exceeding 30%. This retreat naturally raises the question of whether VRSK can work its way back toward the $250 mark.
That round-number level carries weight. It sits modestly above the average 12-month analyst price target of roughly $237.71, so it represents an ambitious but plausible stretch goal. It also lines up with the upper end of many fair-value estimates in the mid-to-high $200s.
Business Snapshot
Verisk supplies data analytics and technology primarily to property-and-casualty insurers. Its underwriting tools assist with rating, pricing, and risk selection, while claims solutions cover repair cost estimates and antifraud capabilities. After streamlining its portfolio through divestitures, the company now concentrates on this core insurance franchise, where the bulk of revenue arrives through recurring subscription contracts.
That model underpins much of the positive case. Over the trailing twelve months, Verisk reported approximately $3.14 billion in revenue and $885.5 million in net income, with gross margins close to 70%. It also distributes a $2.00 per share dividend, equating to a yield of about 1.08% at current prices. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Where the Stock Stands Today
At roughly $185.79, VRSK sits in the middle-to-lower portion of its 52-week range between $155.94 and $273.83. The trailing P/E ratio hovers near 28.6 and the forward P/E near 22.7, consistent with expectations for ongoing earnings growth. With a beta around 0.66, the shares have shown lower volatility than the broader market, reinforcing their reputation as a defensive, cash-generative holding.
Factors That Could Support a Recovery
Several elements could help propel the stock higher. Verisk’s proprietary datasets are deeply integrated into insurer operations, creating switching costs and pricing power. Its subscription revenue base delivers predictable cash flows that support dividends and buybacks. The company is also investing in advanced analytics and AI partnerships that may strengthen rather than erode its position.
If Verisk can maintain mid-single-digit revenue growth, expand margins, and show that AI tools complement its offerings, investors could reward the stock with a higher valuation multiple.
Obstacles to Consider
The main headwind remains uncertainty around AI disruption. Some observers worry that generative AI could allow insurers to develop in-house solutions or enable new entrants to challenge Verisk’s data advantage. Slower organic growth and acquisition-related debt have also tempered sentiment. A recent Delaware court ruling requiring the company to move forward with its planned $2.35 billion purchase of AccuLynx added to the pressure, though Verisk has indicated it may appeal.
Wall Street Views and Targets
Analyst sentiment stays largely positive, though expectations have moderated. Aggregated data point to a consensus 12-month price target near $237.71, suggesting about 28% upside from recent levels, with individual targets spanning roughly $185 to as high as $275–$320. The overall rating is a “Buy,” yet most forecasts now cluster in the low-to-mid $200s, so reaching $250 would mean surpassing the average estimate.
Important Technical Levels
From a technical standpoint, the $155.94 52-week low marks the primary support zone, with further support near $180. On the upside, resistance appears around $195–$200, roughly aligning with the 200-day moving average. Beyond that, the $237 consensus target and the $250 level stand out as the next hurdles that would need to be cleared with conviction and volume.
Valuation Context
Trading at a trailing P/E near 28.6 and forward P/E near 22.7, Verisk commands a premium to certain peers such as Equifax Inc. (EFX). This premium reflects the quality and recurring nature of its revenue, but it also leaves the stock vulnerable to multiple compression if growth or margins disappoint. Achieving $250 would likely require both earnings expansion and a steady or expanding multiple.
Monitoring Momentum with AI Tools
From what I see, staying on top of shifting trends in names like VRSK benefits from systematic signals. In my own process, I’ve found Tickeron’s AI Daily Buy/Sell Signals useful for spotting momentum changes across a broad universe of stocks and ETFs. The tool applies artificial intelligence to generate Buy, Sell, or Hold indications based on technical and market factors, which can help flag potential setups or confirm existing views without replacing broader fundamental work.
Putting It All Together
A return to the $250 area looks feasible over time but is unlikely to happen quickly. Verisk’s entrenched role in insurance data, recurring revenue stream, and free cash flow generation remain its core strengths. Offsetting these are questions around AI disruption, subdued organic growth, and the AccuLynx acquisition overhang. For the target to feel more attainable, sustained revenue acceleration, margin stability, and clearer evidence that its data moat is holding would be needed. In the meantime, the $195–$200 zone and the $237 consensus level are the nearer milestones to watch.
Promo Section
I’ve found Tickeron’s AI Daily Buy/Sell Signals helpful when tracking stocks like VRSK for potential turning points. The platform scans thousands of securities with AI-driven analysis to surface Buy, Sell, or Hold signals based on current conditions. It’s become a regular part of how I monitor positions and identify new opportunities without replacing deeper research.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
VRSK's Indicator enters downward trend
The Aroon Indicator for VRSK entered a downward trend on October 07, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 197 similar instances where the Aroon Indicator formed such a pattern. In 126 of the 197 cases the stock moved lower. This puts the odds of a downward move at 64%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VRSK as a result. In 45 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 54%.
The Moving Average Convergence Divergence Histogram (MACD) for VRSK turned negative on September 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 25 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 54%.
VRSK moved below its 50-day moving average on September 04, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VRSK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 54%.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where VRSK's RSI Oscillator exited the oversold zone, 16 of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 67%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 33 of 54 cases where VRSK's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 61%.
Following a +3.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where VRSK advanced for three days, in 152 of 320 cases, the price rose further within the following month. The odds of a continued upward trend are 47%.
VRSK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 8 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: VRSK's P/B Ratio (74.627) is slightly higher than the industry average of (20.404). P/E Ratio (25.773) is within average values for comparable stocks, (64.718). Projected Growth (PEG Ratio) (1.412) is also within normal values, averaging (2.814). Dividend Yield (0.012) settles around the average of (0.020) among similar stocks. P/S Ratio (7.899) is also within normal values, averaging (25.562).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. VRSK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 81 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VRSK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of decision analytics and risk assessment services
Industry DataProcessingServices
Advertisement